Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer-Reference-Cited by-同舟云学术

Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer

Published:2016-04-13 Issue:9 Volume:37 Page:11927-11936
ISSN:1010-4283
Container-title:Tumor Biology
language:en
Short-container-title:Tumor Biol.

Author:

Chen Xu,Xu Yanmei,Liao Xingyun,Liao Rongxia,Zhang Luping,Niu Kai,Li Tao,Li Dezhi,Chen Zhengtang,Duan Yuzhong,Sun Jianguo

Funder

National Natural Science Foundation of China

Natural Science Foundation of Chongqing

Youth Innovation Foundation of Third Military Medical University

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s13277-016-5052-8.pdf

Reference37 articles.

1. Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, et al. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279population-based registries in 67 countries (CONCORD-2). Lancet. 2015;385(9972):977–1010.

2. Zarogoulidis K, Zarogoulidis P, Darwiche K, Boutsikou E, Machairiotis N, Tsakiridis K, et al. Treatment of non-small cell lung cancer (NSCLC). J Thorac Dis. 2013;5 Suppl 4:S389–96.

3. Brodowicz T, Krzakowski M, Zwitter M, Tzekova V, Ramlau R, Ghilezan N, et al. Central European Cooperative Oncology Group CECOG. Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: a phase III trial. Lung Cancer. 2006;52(2):155–63.

4. Dessard-Diana B, Manoux D, Diana C, Housset M, Baillet F. Discussion on the role of radiotherapy in non-small cell lung cancer apropos of 137 non-metastatic cases. Cancer Radiother. 1997;1(2):154–8.

5. Lindblom E, Dasu A, Toma-Dasu I. Optimal fractionation in radiotherapy for non-small cell lung cancer—a modelling approach. Acta Oncol. 2015;54(9):1592–8.

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MicroRNA-98: the multifaceted regulator in human cancer progression and therapy;Cancer Cell International;2024-06-13

2. Ku70 Functions as an RNA Helicase to Regulate miR-124 Maturation and Neuronal Cell Differentiation;PROG BIOCHEM BIOPHYS;2024

3. MicroRNA in lung cancer—a novel potential way for early diagnosis and therapy;Journal of Applied Genetics;2023-02-23

4. Cell cycle associated miRNAs as target and therapeutics in lung cancer treatment;Heliyon;2022-10

5. Significance of detecting the levels of miR-29a, survivin and interferon gamma release assay in patients with lung cancer and tuberculosis;Advances in Clinical and Experimental Medicine;2022-09-12